Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Preferred A Stock	Additional Paid-In Capital	Accumulated Deficit	Total Stockholders’ Equity attributable to Agrify	Non- Controlling Interests	Total
Balance at Dec. 31, 2021			$ 196,034	$ (58,975)	$ 137,059	$ 365	$ 137,424
Balance (in Shares) at Dec. 31, 2021	111,035
Stock-based compensation			953		953		953
Issuance of Common Stock and warrants in private placement			14,800		14,800		14,800
Issuance of Common Stock and warrants in private placement (in Shares)	12,252
Acquisition of Lab Society			1,903		1,903		1,903
Acquisition of Lab Society (in Shares)	1,490
Exercise of options			10		10		10
Exercise of options (in Shares)	21
Exercise of warrants			1		1		1
Exercise of warrants (in Shares)	7,916
Net income (loss)				1,780	1,780	1	1,781
Balance at Mar. 31, 2022			213,701	(57,195)	156,506	366	156,872
Balance (in Shares) at Mar. 31, 2022	132,714
Balance at Dec. 31, 2022	$ 1		237,875	(247,148)	(9,272)	231	(9,041)
Balance (in Shares) at Dec. 31, 2022	1,038,298
Stock-based compensation			859		859		859
Issuance of Common Stock through an “at the market” offering, net of fees			1,545		1,545		1,545
Issuance of Common Stock through an “at the market” offering, net of fees (in Shares)	323,082
Issuance of Common Stock to Pure Pressure
Issuance of Common Stock to Pure Pressure (in Shares)	366
Vesting of restricted stock units
Vesting of restricted stock units (in Shares)	17
Proceeds from Employee Stock Purchase Plan Shares			25		25		$ 25
Proceeds from Employee Stock Purchase Plan Shares (in Shares)	2,500
Exercise of options (in Shares)							104
Exercise of warrants (in Shares)
Net income (loss)				(10,327)	(10,327)		$ (10,327)
Balance at Mar. 31, 2023	$ 1		$ 240,304	$ (257,475)	$ (17,170)	$ 231	$ (16,939)
Balance (in Shares) at Mar. 31, 2023	1,364,263